Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tazarotene (Zorac) is a synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 32.00 | |
10 mg | In stock | $ 45.00 | |
25 mg | In stock | $ 81.00 | |
50 mg | In stock | $ 150.00 | |
100 mg | In stock | $ 270.00 | |
200 mg | In stock | $ 351.00 | |
500 mg | In stock | $ 593.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Tazarotene (Zorac) is a synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. |
In vitro | Tazarotene causes ERK activation, RB tumor suppressor protein hypophosphorylation, G0 arrest, and myeloid differentiation in HL-60 human myeloblastic leukemia cells. Tazarotene could propel either early or late portions of the period leading to differentiation and G0 arrest and is interchangeable with an RARalpha-selective ligand. [1] Tazarotene therapy regulates gene transcription via interaction with specific nuclear retinoic acid receptors (RARs), thereby modulating the three key pathogenic factors in psoriasis. [2] Tazarotene inhibits the proliferation of fibroblasts and synthesis of DNA and collagen. [3] Tazarotene down-regulates markers of keratinocyte differentiation, keratinocyte proliferation, and inflammation. Tazarotene also up-regulates three novel genes TIG-1 (tazarotene-induced gene-1), TIG-2, and TIG-3, which may mediate an antiproliferative effect. [4] Tazarotene causes growth suppression in retinoid-responsive breast cancer cell lines by up-regulating TIG3. [5] |
In vivo | Tazarotene treatment reduces the number and size of microscopic basal cell carcinomas (BCCs) in UV-treated Ptch1+/? mice. Tazarotene treatment reduces the number and size of microscopic basal cell carcinomas (BCCs) in ionizing radiation-treated Ptch1+/? mice. [5] |
Synonyms | Tazorac, AGN 190168, Zorac |
Molecular Weight | 351.46 |
Formula | C21H21NO2S |
CAS No. | 118292-40-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 35.2 mg/mL (100 mM)
Ethanol: 17.6 mg/mL (50 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tazarotene 118292-40-3 Autophagy Metabolism Retinoid Receptor inhibit Inhibitor RAR/RXR Retinoic acid receptors Tazorac AGN-190168 AGN 190168 Zorac AGN190168 Retinoid X receptors inhibitor